Literature DB >> 25037272

A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference.

Masaki Takahashi1, Hirohiko Hohjoh.   

Abstract

Allele-specific silencing by RNA interference (ASP-RNAi) is an atypical RNAi that is capable of discriminating target alleles from non-target alleles, and may be therapeutically useful for specific inhibition of disease-causing alleles without affecting their corresponding normal alleles. However, it is difficult to design and select small interfering RNA (siRNAs) that confer ASP-RNAi. A major problem is that there are few appropriate measures in determining optimal allele-specific siRNAs. Here we show two novel formulas for calculating a new measure of allele-discrimination, named "ASP-score". The formulas and ASP-score allow for an unbiased determination of optimal siRNAs, and may contribute to characterizing such allele-specific siRNAs.

Mesh:

Substances:

Year:  2014        PMID: 25037272     DOI: 10.1007/s11033-014-3586-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  22 in total

Review 1.  Killing the messenger: short RNAs that silence gene expression.

Authors:  Derek M Dykxhoorn; Carl D Novina; Phillip A Sharp
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

Review 2.  Mechanisms of gene silencing by double-stranded RNA.

Authors:  Gunter Meister; Thomas Tuschl
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 3.  Allele-specific RNA interference for neurological disease.

Authors:  E Rodriguez-Lebron; H L Paulson
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

Review 4.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

5.  Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.

Authors:  Edgardo Rodríguez-Lebrón; Cynthia M Gouvion; Steven A Moore; Beverly L Davidson; Henry L Paulson
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

6.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

7.  Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's disease.

Authors:  Christopher R Sibley; Matthew J A Wood
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

8.  Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.

Authors:  Yusuke Ohnishi; Katsushi Tokunaga; Kiyotoshi Kaneko; Hirohiko Hohjoh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28

9.  Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.

Authors:  Edith L Pfister; Lori Kennington; Juerg Straubhaar; Sujata Wagh; Wanzhou Liu; Marian DiFiglia; Bernhard Landwehrmeyer; Jean-Paul Vonsattel; Phillip D Zamore; Neil Aronin
Journal:  Curr Biol       Date:  2009-04-09       Impact factor: 10.834

10.  Disease-causing allele-specific silencing by RNA interference.

Authors:  Hirohiko Hohjoh
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.